In bladder cancer cells treated with nimbolide, the G2/M phase cell cycle was arrested via the checkpoint kinase 2 (Chk2)/Cdc25C and Chk2/p21WAF1-related cyclin B1/Wee1 pathway. This evidence concerns the gene CDC25C and urinary bladder carcinoma.